NYSE:CC - Chemours Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $38.30 -2.28 (-5.62 %) (As of 03/22/2019 04:00 PM ET)Previous Close$40.58Today's Range$38.29 - $40.4452-Week Range$25.17 - $53.25Volume2.16 million shsAverage Volume1.66 million shsMarket Capitalization$6.37 billionP/E Ratio6.75Dividend Yield2.46%Beta2.31 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, and industrial fluoropolymer resins and derivatives under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals for gold production, oil and gas, water treatment, electronics, and automotive industries. It also provides sodium cyanide through its mining solutions business; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Receive CC News and Ratings via Email Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Chemicals & allied products Sub-IndustryN/A SectorBasic Materials Current SymbolNYSE:CC Previous Symbol CUSIPN/A CIK1627223 Webwww.chemours.com Phone302-773-1000Debt Debt-to-Equity Ratio3.88 Current Ratio1.93 Quick Ratio1.26Price-To-Earnings Trailing P/E Ratio6.75 Forward P/E Ratio8.17 P/E Growth0.55 Sales & Book Value Annual Sales$6.64 billion Price / Sales0.96 Cash Flow$7.4369 per share Price / Cash Flow5.15 Book Value$5.96 per share Price / Book6.43Profitability EPS (Most Recent Fiscal Year)$5.67 Net Income$995 million Net Margins14.99% Return on Equity98.83% Return on Assets13.95%Miscellaneous Employees7,000 Outstanding Shares166,282,000Market Cap$6.37 billion Next Earnings Date5/2/2019 (Estimated) OptionableOptionable Chemours (NYSE:CC) Frequently Asked Questions What is Chemours' stock symbol? Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC." How often does Chemours pay dividends? What is the dividend yield for Chemours? Chemours announced a quarterly dividend on Thursday, February 14th. Stockholders of record on Wednesday, February 27th will be paid a dividend of $0.25 per share on Friday, March 15th. This represents a $1.00 annualized dividend and a dividend yield of 2.61%. The ex-dividend date of this dividend is Tuesday, February 26th. View Chemours' Dividend History. How will Chemours' stock buyback program work? Chemours announced that its board has authorized a share repurchase plan on Monday, December 4th 2017, which permits the company to repurchase $500,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to purchase shares of its stock through open market purchases. Shares repurchase plans are often an indication that the company's leadership believes its stock is undervalued. How were Chemours' earnings last quarter? Chemours Co (NYSE:CC) posted its quarterly earnings data on Thursday, February, 14th. The specialty chemicals company reported $1.05 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.04 by $0.01. The specialty chemicals company earned $1.46 billion during the quarter, compared to analysts' expectations of $1.53 billion. Chemours had a net margin of 14.99% and a return on equity of 98.83%. The firm's revenue for the quarter was down 7.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.19 earnings per share. View Chemours' Earnings History. When is Chemours' next earnings date? Chemours is scheduled to release their next quarterly earnings announcement on Thursday, May 2nd 2019. View Earnings Estimates for Chemours. What guidance has Chemours issued on next quarter's earnings? Chemours updated its FY 2019 earnings guidance on Thursday, February, 14th. The company provided earnings per share guidance of $4.00-5.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.57. Chemours also updated its FY19 guidance to $4.00 to $5.05 EPS. What price target have analysts set for CC? 9 equities research analysts have issued twelve-month price objectives for Chemours' stock. Their forecasts range from $37.00 to $60.00. On average, they anticipate Chemours' stock price to reach $48.1250 in the next year. This suggests a possible upside of 25.7% from the stock's current price. View Analyst Price Targets for Chemours. What is the consensus analysts' recommendation for Chemours? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemours. Has Chemours been receiving favorable news coverage? Headlines about CC stock have been trending positive recently, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Chemours earned a news impact score of 2.2 on InfoTrie's scale. They also assigned headlines about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. Who are some of Chemours' key competitors? Some companies that are related to Chemours include Koninklijke DSM (RDSMY), ASAHI KASEI COR/ADR (AHKSY), FMC (FMC), Johnson Matthey (JMPLY), W. R. Grace & Co (GRA), Huntsman (HUN), Ashland Global (ASH), KURARAY CO LTD/ADR (KURRY), Ingevity (NGVT), Olin (OLN), Univar (UNVR), Balchem (BCPC), GCP Applied Technologies (GCP), PQ Group (PQG) and Innospec (IOSP). What other stocks do shareholders of Chemours own? Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include Micron Technology (MU), NVIDIA (NVDA), Alibaba Group (BABA), DowDuPont (DWDP), Applied Materials (AMAT), Intel (INTC), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Lam Research (LRCX) and E I Du Pont De Nemours And Co (DD). Who are Chemours' key executives? Chemours' management team includes the folowing people: Mr. Mark P. Vergnano, Pres, CEO & Director (Age 61)Mr. Mark E. Newman, Sr. VP & CFO (Age 56)Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 55)Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 62)Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 55) Who are Chemours' major shareholders? Chemours' stock is owned by a variety of of retail and institutional investors. Top institutional investors include FMR LLC (14.63%), BlackRock Inc. (9.80%), Iridian Asset Management LLC CT (5.67%), Bank of New York Mellon Corp (1.84%), LSV Asset Management (1.80%) and Oregon Public Employees Retirement Fund (1.56%). Company insiders that own Chemours stock include Amy Trojanowski, Christian W Siemer, David C Shelton, E Bryan Snell, Erich Parker, Mark Newman, Mark P Vergnano, Paul Kirsch and Richard H Brown. View Institutional Ownership Trends for Chemours. Which institutional investors are selling Chemours stock? CC stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Prudential Financial Inc., Folger Nolan Fleming Douglas Capital Management Inc., BlackRock Inc., Millennium Management LLC, APG Asset Management N.V., Mackay Shields LLC and Westpac Banking Corp. Company insiders that have sold Chemours company stock in the last year include Amy Trojanowski, Erich Parker, Mark Newman, Mark P Vergnano and Paul Kirsch. View Insider Buying and Selling for Chemours. Which institutional investors are buying Chemours stock? CC stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Norges Bank, LSV Asset Management, Bank of New York Mellon Corp, Thrivent Financial for Lutherans, Canada Pension Plan Investment Board, Teacher Retirement System of Texas and Private Management Group Inc.. View Insider Buying and Selling for Chemours. How do I buy shares of Chemours? Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Chemours' stock price today? One share of CC stock can currently be purchased for approximately $38.30. How big of a company is Chemours? Chemours has a market capitalization of $6.37 billion and generates $6.64 billion in revenue each year. The specialty chemicals company earns $995 million in net income (profit) each year or $5.67 on an earnings per share basis. Chemours employs 7,000 workers across the globe. What is Chemours' official website? The official website for Chemours is http://www.chemours.com. How can I contact Chemours? Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19899. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected] MarketBeat Community Rating for Chemours (NYSE CC)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 333 (Vote Outperform)Underperform Votes: 379 (Vote Underperform)Total Votes: 712MarketBeat's community ratings are surveys of what our community members think about Chemours and other stocks. Vote "Outperform" if you believe CC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/22/2019 by MarketBeat.com StaffFeatured Article: What are the advantages of the Stochastic Momentum Index?